Flex Joint
Flex Joint, licence 80134715: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Glucosamine Chondroitin & MSM, Glucosamine Complex, Super Joint Care, Ultimate Move Free, Ultimate joint care
- Licence holder
- Herba Health Inc.
- NPN or DIN-HM
- 80134715
- Status
- Active licence
- Licence date
- 27 September 2024
- Revision date
- 14 February 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Boswellia serrata - Oléo-gomme-résine (écorce de tige) Potency : 40.0 % (p/p) Boswellic acids | 30.0 mg | Not calculated |
| Sulfate de chondroïtine Source : Bos taurus - cartilage | 50.0 mg | Not calculated |
| Curcuminoïdes Source : Curcuma longa - rhizome | 30.0 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 10.0 mg | Not calculated |
| Sulfone de diméthyl Source : Sulfone de diméthyl | 100.0 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose | 375.0 mg | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus var. comosus - fruit | 1080000.0 FCC PU | Not calculated |
| Collagène hydrolysé | 30.0 mg | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome Extract : Matériel brut sec Extraction ratio : 4.000:1 Dry plant equivalent : 60 mg | 15.0 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Farine de riz brun, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in maintaining healthy cartilage and/or joint health. Helps to protect against the deterioration of cartilage. Helps to relieve pain associated with osteoarthritis of the knee. Used in Herbal Medicine to help relieve minor pain, swelling and inflammation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80134715
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.